Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FJ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.80NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.80NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CR.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CR.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DF.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CK.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GL.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GL.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.78NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.78NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.37.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.37.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.77NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FD.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used